Early and Intense Flu Season Revs Up
Drug Topics
DECEMBER 2, 2022
Flanked by RSV and COVID-19, flu season started early and rates of transmission are high throughout the country.
Sat.Nov 26, 2022 - Fri.Dec 02, 2022
551 
5 enduring mysteries of the Barry and Honey Sherman murders
PharmaVoice
NOVEMBER 28, 2022
After nearly five years, the homicide case involving pharma billionaires continues to perplex investigators.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)
IDStewardship
DECEMBER 1, 2022
In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Authored By: Lucia Rose, PharmD, BCIDP. Article Posted 1 December 2022. It was the fall of 2009; I was a proud PGY-1 resident at UMass Medical Center rounding with a large team in the ICU.
Stories from the lab: Researchers discuss innovative treatments for cancers of the blood
PhRMA
DECEMBER 1, 2022
The biopharmaceutical industry is one of the most research-intensive of all sectors in the U.S. economy and supports a broad range of STEM jobs through R&D and manufacturing. At the backbone of the biopharmaceutical ecosystem are its researchers. Each day, in labs across the country, these individuals work tirelessly on the front lines of research and development to help bring novel medicines to patients.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Black Patients Face Disparities for CGMs, Insulin Pumps
Drug Topics
NOVEMBER 29, 2022
New research adds more evidence of Black patients facing disparities in diabetes care.
Non-toxic and addiction free: The promise of a new pain med
PharmaVoice
DECEMBER 1, 2022
Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Many Feel US Health Care Puts Profit Over Patients
Drug Topics
NOVEMBER 28, 2022
The fight to put the consumer first in health care remains as many Americans feel the industry is still putting the mighty dollar ahead of patients.
Avoiding a ‘bad trip’ in psychedelic clinical trials
PharmaVoice
NOVEMBER 28, 2022
Psychedelic drug trials pose a number of challenges, but researchers can take these steps to boost patient safety.
Anticipated Developments on the Horizon for Patients With HR+/HER2- Breast Cancer
Pharmacy Times
NOVEMBER 30, 2022
Expert panelists discuss potential coming developments in the treatment landscape for breast cancer.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
What they are saying: PASTEUR Act can help fight antimicrobial resistance
PhRMA
NOVEMBER 30, 2022
Antimicrobial resistance (AMR) is a growing health crisis resulting in nearly 50,000 U.S. deaths each year and 1.27 million globally on an annual basis – higher than HIV/AIDS and malaria. To slow and control continued AMR, we need a robust pipeline of novel products, and at the same time we need to ensure they are used only in a limited set of circumstances and in only the most necessary cases.
Global Measles Threat Increases due to Decline in Vaccine Coverage
Drug Topics
NOVEMBER 28, 2022
The COVID-19 pandemic disrupted routine immunization programs around the world.
Healthcare tech’s biggest busts
PharmaVoice
DECEMBER 2, 2022
The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.
Walgreens to Eliminate Task-Based Metrics in Evaluation of Pharmacy Staff
Pharmacy Times
NOVEMBER 28, 2022
Walgreens plans to focus on improving pharmacy staffing and retaining and rewarding current staff.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Alzheimer’s researchers try out an unfamiliar sensation: optimism
STAT
DECEMBER 2, 2022
SAN FRANCISCO — Scientific meetings about Alzheimer’s disease can be funereal affairs, with researchers from around the world gathering in hopes that the latest in a long line of negative clinical trials might light the path to a long-awaited success. This year was different. Nearly 2,000 people showed up to the Clinical Trials in Alzheimer’s Disease meeting, a conference record, to hear about lecanemab, a drug from Eisai and Biogen that appears to have broken the decades-lo
Co-Administering Influenza and Shingles Vaccines May Reduce Vaccine Uptake for the Next Flu Season
Drug Topics
DECEMBER 1, 2022
Although it’s safe and recommended to co-administer these shots, research finds a reduction in flu vaccine uptake the following year.
5 final FDA action dates to watch this year
PharmaVoice
DECEMBER 1, 2022
A potential flurry of regulatory activity could be on the horizon yet this year — and several key drug approvals are at stake.
More vaccinated than unvaccinated died from COVID-19 in August: analysis
Fierce Healthcare
NOVEMBER 28, 2022
More vaccinated than unvaccinated died from COVID-19 in August: analysis. fdiamond. Mon, 11/28/2022 - 16:34.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Trajectory of HR+/HER2- Breast Cancer Treatment
Pharmacy Times
NOVEMBER 30, 2022
Drs McHayleh and Vinokurov share final thoughts, highlighting the future of treatment for HR+/HER2- breast cancer.
Safety Questions Remain for Alzheimer's Treatment Lecanemab
Drug Topics
DECEMBER 1, 2022
Lecanemab is an investigational anti-amyloid beta antibody to treat mild cognitive impairment due to Alzheimer’s disease. It is currently under review by the FDA and a decision is expected by January 6, 2023.
Evommune’s unique method of drug discovery is more than skin deep
PharmaVoice
NOVEMBER 29, 2022
The biotech is using human skin squares from plastic surgery to find the best immunological molecules for solving conditions like dermatitis.
After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback
STAT
NOVEMBER 29, 2022
He Jiankui, the Chinese biophysicist who created the first gene-edited children , had been quiet since completing a three-year prison sentence in April, leaving many to wonder whether he had plans to return to scientific research. Earlier this month, we got his answer. On Nov. 9, He posted photos to Twitter of himself sitting at a computer in a white office.
Pharmacists Play Essential Role in Addressing Health Care Disparities
Pharmacy Times
DECEMBER 2, 2022
Diversity, equity, and inclusion programs in pharmacy can lead to better health outcomes for patients.
Recession Ahead: How to Prepare Your Pharmacy
Drug Topics
NOVEMBER 30, 2022
Many independent pharmacies closed during the last recession.
10 of our most popular articles in 2022
PharmaVoice
NOVEMBER 30, 2022
Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.
STAT+: Detailed data on Alzheimer’s therapy from Eisai, Biogen hold up to scientific scrutiny
STAT
NOVEMBER 29, 2022
SAN FRANCISCO — A closely watched new treatment for Alzheimer’s disease held up to scrutiny in a detailed scientific presentation Tuesday, as its developers, partners Eisai and Biogen, begin the lengthy process of turning this medicine into what they hope could be a groundbreaking therapy. The drug, lecanemab, slowed the cognitive and functional decline of patients with early-stage Alzheimer’s by 27% relative to placebo in a roughly 2,000-volunteer clinical trial.
Telehealth Availability Is Linked to Better Mental Health Engagement in Those With Medicaid
Pharmacy Times
DECEMBER 2, 2022
Data show that despite declines in visit rates to federally qualified health centers, patients with psychological disorder diagnoses during COVID-19 did well when telemedicine was available.
Does Your Vaccine Storage System Protect Patients and Your Business?
Drug Topics
NOVEMBER 29, 2022
Drug Topics® is joined by Madeline Camejo, MS, PharmD, to vaccine storage systems, the common challenges linked to them, and the best practices that pharmacies should adopt to ensure safe storage.
Industry Voices—The changing digital health landscape
Fierce Healthcare
DECEMBER 2, 2022
Industry Voices—The changing digital health landscape. hlandi. Fri, 12/02/2022 - 11:20.
Opinion: Congress: Close the gap between funding for nutrition research and the toll diet-related disease takes on Americans
STAT
DECEMBER 2, 2022
You are what you eat. Every year, new scientific discoveries make clear that food is critical to health. In recent years, nutrition research trials have shown that a Mediterranean diet reduces cardiovascular disease; ultra-processed foods increase weight gain; omega-3 fatty acids improve IQ in preterm babies; cocoa prevents heart attacks; and vitamin D supplements do — well, almost nothing.
Tune in for Coverage of the 2022 San Antonio Breast Cancer Symposium
Pharmacy Times
DECEMBER 2, 2022
Pharmacy Times® will be onsite in Texas providing written and video content for the SABCS, which takes place December 6 to 10.
Looking at Barriers to Childhood Vaccinations
Drug Topics
NOVEMBER 28, 2022
A recent poll showed that some parents do not discuss vaccines with their child’s regular doctor, with many choosing to not have their child receive any vaccines.
Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023
Fierce Healthcare
DECEMBER 2, 2022
Digital health VCs eye healthcare workforce, cancer care as ripe for startups in 2023. hlandi. Fri, 12/02/2022 - 06:26.
Let's personalize your content